Oncology

Tachyon

Clinical-stage company developing first-in-class small molecule therapeutics against novel targets from previously unexplored cancer dysregulation pathways to propel new options for the treatment of advanced cancers.

Red Tree Participation
Co-investor in Seed round

Red Tree Board Member

Jennifer Cochran, Ph.D.

Total Addressable Market
Red Tree Board Member(s)

Red Tree Board Member

Jennifer Cochran, Ph.D.

Red Tree Participation
Co-investor in Seed round

Tachyon

Oncology
Total Addressable Market
Red Tree Board Member(s)

Red Tree Board Member

Jennifer Cochran, Ph.D.

Red Tree Participation
Co-investor in Seed round